Anonymous ID: 203d3c July 9, 2021, 8:02 p.m. No.14091661   🗄️.is 🔗kun

>>14091347 (lb)

>>14091573 (lb)

>>14091525 (lb)

 

this anon needs to clock off. HIPC if anyone is bored and looking for a dig. wonder if Lynn d R angle, probably Fauci involved.

 

e.g.,

 

Today, a new NIAID-supported study has begun to track the immune responses of people hospitalized with COVID-19 in 10 research sites across the United States. Investigators in NIAID’s Human Immunology Project Consortium (HIPC) in collaboration with researchers in the Asthma and Allergic Diseases Clinical Research Consortium (AADCRC) and other NIAID-funded groups, aim to determine how certain immunological measures correspond to, or may even predict, the clinical severity of COVID-19. Participants will be followed for up to 12 months after their hospitalization to assess how well they recover and whether they develop durable immunity to the virus. The Immunophenotyping Assessment in a COVID-19 Cohort, or IMPACC, study also will investigate the relationship between COVID-19 severity and the amount of virus found in nasal secretions or in the lower airways. Data collected in the IMPACC study will help inform recommendations for COVID-19 care and, hopefully, identify new targets and optimal timing for experimental treatments.

 

Led by protocol chair Nadine Rouphael, M.D., chair of the HIPC Clinical Subcommittee and an associate professor at the Emory University School of Medicine, with the support of Clinical & Data Coordinating Center (CDCC) lead Al Ozonoff, Ph.D., ofBoston Children’s Hospital’s Precision Vaccines Program,and associate professor at Harvard Medical School, IMPACC will enroll as many as 2,000 individuals who have been hospitalized with COVID-19.Researchers will enroll participants within 36 hours of their admission to the hospital and follow them for up to one year.Investigators will collect blood and nasal swabs from study participants throughout their hospitalization and during follow-up clinic visits after they have been discharged. When possible, researchers will also examine lower airway secretions collected from patients requiring a ventilator for breathing support. Participants can be co-enrolled in other studies, such as those evaluating experimental treatments for COVID-19.

 

https://www.niaid.nih.gov/news-events/niaid-study-examines-immune-responses-people-covid-19

 

[was COVID-19 a fukking nazi biowarfare experiment?]